About US
Contact us
-
Fast-growing Celgene snaps up Merck's abandoned NJ campusOut with the old guard, in with the new. In another sign that Big Biotech is elbowing into the top levels of pharma, Celgene has agreed to buy Merck & Co.'s old campus in Summit, NJ, adding the sp2015/7/6
-
With vet drugs pumping, it's no wonder that pharma's eyeing M&AWhat's with all the M&A rumors floating around in the animal health world? Just look at Zoetis' ($ZTS) Apoquel and it's clear why Big Pharma names are keen to bolster their positions in the space.2015/7/6
-
2015 International Food Safety Conference held in BeijingOn June 15, 2015, the 2015 International Food Safety Conference was held in Beijing, as an important activity of the China Food Safety Publicity Week. Bi Jingquan, Minister of China Food and Drug Admi2015/7/3
-
Fast-growing Celgene snaps up Merck's abandoned NJ campusOut with the old guard, in with the new. In another sign that Big Biotech is elbowing into the top levels of pharma, Celgene has agreed to buy Merck & Co.'s old campus in Summit, NJ, adding the sp2015/7/3
-
With vet drugs pumping, it's no wonder that pharma's eyeing M&AWhat's with all the M&A rumors floating around in the animal health world? Just look at Zoetis' ($ZTS) Apoquel and it's clear why Big Pharma names are keen to bolster their positions in the space.2015/7/3
-
The 2015 edition of Chinese Pharmacopoeia to enhance the overall level of China's drug qualityThe 2015 edition of Chinese Pharmacopoeia was recently adopted at the plenary session of the Executive Committee of the Tenth Chinese Pharmacopoeia Commission. On June 5, 2015, China Food and Drug Adm2015/7/2
-
Drug Administration Law of the People's Republic of ChinaOrder of the President of the Peoples Republic of China (No. 45) The Drug Administration Law of the People’s Republic of China, revised at the 20th Meeting of the Standing Committee of the Ninth Nat2015/7/2
-
Bad news for AstraZeneca: FDA lays out roadmap for would-be Symbicort copycatsCourtesy of AstraZeneca The FDA has issued AstraZeneca's ($AZN) least favorite form of draft guidance--the kind that helps other drugmakers develop copies of a blockbuster seller. Regulato2015/7/2
-
Bayer, J&J aim to protect Xarelto's market lead with focus on clinical dataBayerand Johnson & Johnson ($JNJ) know that right now, there's an impression out there that rival drugEliquis--from Pfizer ($PFE) and Bristol-Myers Squibb ($BMY)--is superior to their next-gen clo2015/7/2
-
CFDA officially joins the Interim Management Committee of ICMRAUpon the approval of the State Council, China Food and Drug Administration (CFDA) officially joined the Interim Management Committee of the International Coalition of Medicines Regulatory Authorities2015/7/1